These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 392051)

  • 1. The sensitivity of measles virus haemolysin to acetone and the preparation of mono-specific human anti-haemolysin by absorption.
    Armstrong MA; Fraser KB; Shirodaria PV
    J Gen Virol; 1979 Aug; 44(2):541-4. PubMed ID: 392051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity for measles virus anti-haemolysin of a residual immunoglobulin M in sera of some patients with multiple sclerosis.
    Fraser KB; Armstrong M; Shirodaria PV; Gharpure M
    Clin Exp Immunol; 1979 May; 36(2):304-10. PubMed ID: 383332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the immunological relationship between measles virus and canine distemper virus using monospecific measles antisera.
    Gould EA; Armstrong M; Shirodaria PV; De'Ornellas D
    J Med Virol; 1981; 7(1):51-60. PubMed ID: 6165804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoelectron microscopic studies on haemagglutinin and haemolysin of measles virus in infected HEp2 cells.
    Armstrong MA; Fraser KB; Dermott E; Shirodaria PV
    J Gen Virol; 1982 Mar; 59(Pt 1):187-92. PubMed ID: 6175729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies specific for measles virus envelope antigens and autoantibodies in patients with chronic active hepatitis.
    Shirodaria PV; McMillan SA; Callender ME; Haire M; Fleming E; Merrett JD; Fulton TT
    J Clin Pathol; 1985 Nov; 38(11):1281-8. PubMed ID: 3905870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies.
    Norrby E; Gollmar Y
    Infect Immun; 1975 Feb; 11(2):231-9. PubMed ID: 803467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembrane communication in cells chronically infected with measles virus.
    Tyrrell DL; Ehrnst A
    J Cell Biol; 1979 May; 81(2):396-402. PubMed ID: 381319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles virus-specific antibodies and immunoglobulin M antiglobulin in sera from multiple sclerosis and rheumatoid arthritis patients.
    Shirodaria PV; Fraser KB; Armstrong M; Roberts SD
    Infect Immun; 1979 Jul; 25(1):408-16. PubMed ID: 314421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antigenic activity of measles immunostimulating complex].
    Mamaeva TA; Tikhonova NT; Starov AI; Naumova MA; Vysotskiĭ VV
    Vopr Virusol; 1998; 43(3):127-9. PubMed ID: 9702812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic characterization of measles and SSPE virus haemagglutinin by monoclonal antibodies.
    ter Meulen V; Löffler S; Carter MJ; Stephenson JR
    J Gen Virol; 1981 Dec; 57(Pt 2):357-64. PubMed ID: 6172558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of human antibody to the fusion protein of measles virus.
    Sato TA; Kohama T; Sugiura A
    Microbiol Immunol; 1989; 33(7):601-7. PubMed ID: 2671610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen mimicry involving measles virus hemagglutinin and human respiratory syncytial virus nucleoprotein.
    Norrby E; Sheshberadaran H; Rafner B
    J Virol; 1986 Jan; 57(1):394-6. PubMed ID: 2416956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization.
    de Swart RL; Yüksel S; Osterhaus AD
    J Virol; 2005 Sep; 79(17):11547-51. PubMed ID: 16103210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth phase related loss of measles virus surface-associated antigens and cytotoxic susceptibility in persistently infected cells.
    Ehrnst A
    J Gen Virol; 1979 Dec; 45(3):547-56. PubMed ID: 396361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of measles virus-specific cytotoxic antibodies by use of a chronically infected cell line.
    Ehrnst AC
    J Immunol; 1975 Mar; 114(3):1077-82. PubMed ID: 1089724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Method for detecting antimeasles antihemolysins in sera].
    Mamaeva TA; Tikhonova NT; Danilova GB; Khrometskaia TM
    Vopr Virusol; 1986; 31(2):241-5. PubMed ID: 3524003
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway.
    Joseph BS; Cooper NR; Oldstone MB
    J Exp Med; 1975 Apr; 141(4):761-74. PubMed ID: 1092789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of major structural proteins of measles virus with monoclonal antibodies.
    Sato TA; Fukuda A; Sugiura A
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1397-409. PubMed ID: 2410551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-mediated cytotoxicity after measles virus infection.
    Kibler R; Meulen VT
    J Immunol; 1975 Jan; 114(1 Pt 1):93-8. PubMed ID: 803529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a new neutralization test for measles virus.
    Fujino M; Yoshida N; Kimura K; Zhou J; Motegi Y; Komase K; Nakayama T
    J Virol Methods; 2007 Jun; 142(1-2):15-20. PubMed ID: 17320979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.